Ocriplasmin
Jetrea (ocriplasmin) is an enzyme pharmaceutical. Ocriplasmin was first approved as Jetrea on 2013-03-13. It is used to treat retinal diseases in the USA. It has been approved in Europe to treat retinal diseases.
| Trade Name | Jetrea |
|---|---|
| Common Name | Ocriplasmin |
| Indication | retinal diseases |
| Drug Class | Plasmin proteins and derivatives |
